Atossa Therapeutics: Betting Big On Transforming Old Breast Cancer Care (NASDAQ:ATOS)
andresr Topline Summary Atossa Therapeutics (NASDAQ:ATOS) in a biotech company focused on the development of a novel hormone therapy for women with the most common subgroup of breast cancer: hormone receptor-positive disease. Although they have funds to continue for a few more years, the indications they’re chasing are going to be very tough, with a…